Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruibao Ren

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Leukemia & Lymphoma|October 29, 2002
Dissecting the molecular mechanism of chronic myelogenous leukemia using murine modelsRuibao Ren
Current Opinion in Hematology|December 17, 2003
Modeling the dosage effect of oncogenes in leukemogenesisRuibao Ren
Oncogene|December 12, 2002
The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine modelRuibao Ren
Nature Reviews. Cancer|February 19, 2005
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemiaRuibao Ren
Methods in Enzymology|April 1, 2008
Mouse model for NRAS-induced leukemogenesisChaitali Parikh, Ruibao Ren
Frontiers of Medicine|November 23, 2013
The role of RAS effectors in BCR/ABL induced chronic myelogenous leukemiaJessica Fredericks, Ruibao Ren
Blood|March 5, 2010
Palmitoylation of oncogenic NRAS is essential for leukemogenesisBenjamin Cuiffo, Ruibao Ren
Oncogene|January 16, 2004
Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in miceGrace M Cuenco, Ruibao Ren
The Journal of Biological Chemistry|November 24, 2011
IRF-4 suppresses BCR/ABL transformation of myeloid cells in a DNA binding-independent mannerSeung-Hee Jo, Ruibao Ren
Journal of Hematology & Oncology|June 26, 2008
Effect of Ras inhibition in hematopoiesis and BCR/ABL leukemogenesisKarina J Baum, Ruibao Ren
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Leukemia & Lymphoma|October 29, 2002
Dissecting the molecular mechanism of chronic myelogenous leukemia using murine modelsRuibao Ren
Current Opinion in Hematology|December 17, 2003
Modeling the dosage effect of oncogenes in leukemogenesisRuibao Ren
Oncogene|December 12, 2002
The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine modelRuibao Ren
Nature Reviews. Cancer|February 19, 2005
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemiaRuibao Ren
Methods in Enzymology|April 1, 2008
Mouse model for NRAS-induced leukemogenesisChaitali Parikh, Ruibao Ren
Frontiers of Medicine|November 23, 2013
The role of RAS effectors in BCR/ABL induced chronic myelogenous leukemiaJessica Fredericks, Ruibao Ren
Blood|March 5, 2010
Palmitoylation of oncogenic NRAS is essential for leukemogenesisBenjamin Cuiffo, Ruibao Ren
Oncogene|January 16, 2004
Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in miceGrace M Cuenco, Ruibao Ren
The Journal of Biological Chemistry|November 24, 2011
IRF-4 suppresses BCR/ABL transformation of myeloid cells in a DNA binding-independent mannerSeung-Hee Jo, Ruibao Ren
Journal of Hematology & Oncology|June 26, 2008
Effect of Ras inhibition in hematopoiesis and BCR/ABL leukemogenesisKarina J Baum, Ruibao Ren
Pageof 7